医疗器械板块飙升，医疗设备ETF(159873)冲高涨近3%，涨幅高居全市ETF前十，第十一批国家组织药品集采报量正式启动

Group 1 - The medical device ETF (159873) experienced a significant increase, rising nearly 3% and ranking among the top ten ETFs in the market as of August 7, 2025 [3] - The underlying index, the CSI All Share Medical Equipment and Services Index (H30178), saw a strong rise of 1.57%, with notable individual stocks like Lide Man (300289) up 20.02%, Sino Medical (688108) up 20.01%, and Zhonghong Medical (300981) up 19.99% [3] - Over the past week, the medical device ETF (159873) achieved an average daily trading volume of 7.11 million yuan, ranking first among comparable funds [3] Group 2 - The eleventh batch of national drug centralized procurement has officially started, with the National Healthcare Security Administration announcing the collection of demand for 55 drug varieties from August 6 to 25 [4] - According to CITIC Securities, there is a possibility of price increases for categories already included in national or provincial procurement, while categories not yet included may see moderate price reductions or not be procured at all [4] - Xiangcai Securities noted that the innovative drug industry chain has been active under the backdrop of national encouragement for innovation, although the recovery of the pharmaceutical industry still needs verification [4] Group 3 - The Biopharmaceutical ETF (159859) and its linked funds are the largest and most liquid products in the sector, with the highest year-to-date growth among comparable funds, covering various segments including innovative drugs and vaccines [5] - The Tianhong Innovative Drug ETF (517380) is the only ETF tracking the Hang Seng Shanghai-Shenzhen Hong Kong Innovative Drug Selected 50 Index, providing comprehensive coverage of both A-shares and Hong Kong stocks [5]